Pharmafile Logo
Pharmafocus logo
Advanced Search

Allegro shares promising preclinical results for osteoarthritis treatment

March 26, 2025
Clinical Trial Services, Research and Development Allegro, Orthopaedics, biomedical, clinical studies, osteoarthritis

Allegro has announced that hydrocelin, its injectable microparticle hydrogel, showed no signs of toxicity in two preclinical studies. Allegro is …

News

Pharming Group doses first patient in phase 2 trial of leniolisib in CVID

March 26, 2025
Clinical Trial Services, Research and Development CVID, Immunology, Pharming Group, clinical trial, common variable immunodeficiency, immunodeficiency

Pharming Group has announced that the first patient has been dosed in a phase 2 clinical trial evaluating leniolisib in …

News
handshake_2

Cold Chain Technologies acquires Global Cold Chain Solutions

March 26, 2025
Dedicated cold-chain delivery, Manufacturing and Production Global Cold Chain Solutions, Pharmacy, business development, cold chain, life sciences, partnership

Cold Chain Technologies (CCT), a global provider for temperature-sensitive packing and digital solutions, has acquired Global Cold Chain Solutions (GCCS), …

News

Gary Lyons appointed as EVP medical affairs of Coronado Research

March 26, 2025
Business Services, Consultancy Consultancy, Coronado Research, Medical Affairs, Pharmacy, appointment

Coronado Research, a UK-based consultancy-led organisation, has announced that it has appointed Gary Lyons as executive vice president (EVP) for …

Appointment

Takeda announces launch of Framework to help support patient access to life-extending combination treatments

February 25, 2025
Business Services Cancer, HIV/AIDS, Immunology, NHS, NICE, Oncology, Takeda, VPAG, patient access

The Conceptual Implementation Framework outlines critical points within the UK healthcare access ecosystem to help improve the introduction of combination …

News
Press release

Recce Pharmaceuticals reports positive phase 2 data for skin infection drug

February 17, 2025
Research and Development Recce, Skin, diabetes, skin, skin infections

Recce Pharmaceuticals have announced positive patient data from its phase 2 clinical trial into RECCE 327 (R327), for the treatment …

News

PulseSight Therapeutics closes Series A financing for dry AMD phase 1 clinical study

February 14, 2025
Clinical Research Opthalmology, age-related macular degeneration, clinical trials

Ophthalmology biotech PulseSight Therapeutics has confirmed the closure of its Series A funding round, the proceeds of which will be …

News

Cardinal Health’s Kangaroo OMNI™ Enteral Feeding Pump to launch in new international markets in 2025

February 6, 2025
Sales and Marketing Kangaroo, enteral, feeding pump

The next generation Kangaroo OMNI™ enteral feeding pump delivers nutrition and hydration from hospital to home. DUBLIN, Ireland, Feb.4, 2025 …

News
Press release
1200px-european_flag_in_karlskrona_2011

European Commission launches new Biotech and Biomanufacturing Hub

February 3, 2025
Research and Development Biomanufacturing, Corporate, European Commission, Hub, european union

The European Commission has announced the opening of a new Biotech and Biomanufacturing Hub, supporting start-ups and small- to medium-sized …

News

FlyPharma 2025 Amsterdam officially announced as contracts are signed with host sponsors

February 3, 2025
Business Services, Conferences Air France KLM Martinair Cargo ., Amsterdam Airport Schiphol, Corporate, DHL Global Forwarding, FlyPharma Conferences, logistics

FlyPharma, the leading platform for the pharmaceutical logistics and supply chain industry, is thrilled to announce its ninth European conference, …

News

Prenatal care could be revolutionised suggests studies from BrightHeart

January 31, 2025
Research and Development AI, BrightHeart, FDA, Obstetrics & Gynaecology, prenatal, studies

Private medical device and artificial intelligence (AI)-led company, BrightHeart, has revealed two studies which show an improvement to pre-natal care …

News

CANDOR Bioscience acquired by Medix Biochemica

January 31, 2025
Sales and Marketing CANDOR biosciences, Diagnostics, Medix biochemica, acquisition, in vitro diagnostics

CANDOR Biosciences, a supplier in immunoassay solutions, has been acquired by Medix Biochemica, a supplier of raw materials for in …

News

MHRA approve new treatment combo for transplant-ineligible multiple myeloma patients

January 30, 2025
Research and Development MHRA, Oncology, approvals, multiple myeloma, rare diseases

The Medicine and Healthcare products Regulatory Agency (MHRA) has approved quadruplet therapy, SARCLISA (isatuximab) in combination to treat multiple myeloma …

News

Bayer UK Launches New CanesMeno® Educational Hub and Product Range to Transform Menopause Support

January 30, 2025
Medical Communications

29 January 2025 – Reading, UK – Bayer Consumer Health is entering the menopause category for the first time in …

News
Press release

NICE issues positive final guidance for treatment of Duchenne Muscular Dystrophy from Santhera

January 29, 2025
Sales and Marketing Duchenne Muscular Dystrophy, EC, EMA, FDA, Santhera Pharmaceuticals, positive

Santhera Pharmaceuticals has received positive final guidance from the National Institute for Care and Excellence (NICE) for AGAMREE (vamorolone) to …

News

Positive topline results announced in phase 2 Alcohol Use Disorder study

January 29, 2025
Research and Development Beckley Psytech Ltd, King's College University, Poisoning and drug dependency, alcohol use disorder, clinical trials, positive results

Beckley Psytech Ltd, a clinical-stage biopharmaceutical company that specialises in the production of accessible medicines for mental health conditions, has …

News

Results from Novadip phase 1b/2a trial reveal 88% efficacy

January 28, 2025
Clinical Research Congenital Pseudoarthritis of the Tibia, Rare Diseases, clinical trials, efficacy, paediatric, rare diseases

Novadip Biosciences, a clinical stage biotechnology company with a specialty in regenerative medicine, has announced the results of its 12-month …

News
handshake2

Jérôme Berger announced as strategy and finance executive at Vect-Horus

January 28, 2025
appointment, private biotechnology company

Vect-Horus, a private biotechnology company specialising in molecular development, has announced the appointment of Jérôme Berger to its board of …

Appointment

Research collaboration announced between Oxford University and GSK

January 27, 2025
Research and Development Cancer, Oncology, Oxford University, neoantigens, partnership, research and development

The GSK-Oxford Cancer Immuno-Prevention Programme was announced at the end of January and will focus on researching the prevention of …

News

Pharmapack Award Winners 2025 redefining pharmaceutical packaging and drug delivery

January 23, 2025
Paris, Pharmapack 2025, Winners, pharmaceutical packaging and drug delivery

Award winners by category DELIVERY AND DEVICE INNOVATION SHL Medical for Elexy™ reusable electromechanical autoinjector ECO-DESIGN WINNER Huhtamaki for Omnilock™ …

News
Press release
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026